{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T08:17:56Z","timestamp":1771834676721,"version":"3.50.1"},"reference-count":30,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2025.2025.0193","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:22:58Z","timestamp":1756290178000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Prognostic Features of Erythrodermic Cutaneous T-Cell Lymphoma: A Retrospective Study of 35 Patients"],"prefix":"10.4274","author":[{"given":"Hatice","family":"Sanli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handan Merve","family":"Erol Mart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikmet B. Bayindir","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Oktem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengu N.","family":"Akay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/1346-8138.15114","article-title":"Two distinct variants of mycosis fungoides (MF): folliculotropic MF and erythrodermic MF","volume":"46","author":"Kamijo","year":"2019","unstructured":"1. Kamijo H, Sugaya M. Two distinct variants of mycosis fungoides (MF): folliculotropic MF and erythrodermic MF. J Dermatol. 2019;46:1136-1140.","journal-title":"J Dermatol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-4632.2009.03771.x","article-title":"Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma","volume":"48","author":"Vidulich","year":"2009","unstructured":"2. Vidulich KA, Talpur R, Bassett RL, Duvic M. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Int J Dermatol. 2009;48:243-252.","journal-title":"Int J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.2340\/00015555-3306","article-title":"The microRNA expression profile differs between erythrodermic mycosis fungoides and S\u00e9zary syndrome","volume":"99","author":"Rittig","year":"2019","unstructured":"3. Rittig AH, Lindahl LM, Johansen C, Celis P, \u00d8dum N, Iversen L, Litman T. The microRNA expression profile differs between erythrodermic mycosis fungoides and S\u00e9zary syndrome. Acta Derm Venereol. 2019;99:1148-1153.","journal-title":"Acta Derm Venereol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","unstructured":"4. Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood. 2010;116:767-771.","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"EC","year":"2002","unstructured":"5. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R; ISCL. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002;46:95-106.","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/JID.2015.360","article-title":"Expression of S\u00e9zary biomarkers in the blood of patients with erythrodermic mycosis fungoides","volume":"136","author":"Hurabielle","year":"2016","unstructured":"6. Hurabielle C, Michel L, Ram-Wolff C, Battistella M, Jean-Louis F, Beylot-Barry M, d'Incan M, Bensussan A, Bagot M. Expression of S\u00e9zary biomarkers in the blood of patients with erythrodermic mycosis fungoides. J Invest Dermatol. 2016;136:317-320.","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Diamandidou E, Colome M, Fayad L, Duvic M, Kurzrock R. Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome. J Am Acad Dermatol. 1999;40(6 Pt 1):914-924.","DOI":"10.1016\/S0190-9622(99)70079-4"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","unstructured":"8. Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, Wei W, Duvic M. Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009. Clin Cancer Res. 2012;18:5051-5060.","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, Prince HM, Quaglino P. Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now? Br J Dermatol. 2014;170:1226-1236.","DOI":"10.1111\/bjd.12909"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.07.007","article-title":"Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis","volume":"64","author":"Miyagaki","year":"2011","unstructured":"10. Miyagaki T, Sugaya M. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis. J Dermatol Sci. 2011;64:1-6.","journal-title":"J Dermatol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/bjd.20580","article-title":"Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases","volume":"185","author":"Skayem","year":"2021","unstructured":"11. Skayem C, Beylot-Barry M, de Masson A, Dereure O, Ram-Wolff C, Bagot M, Vergier B, Battistella M, Ortonne N, Ingen-Housz-Oro S. Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T-cell lymphoma: nine cases. Br J Dermatol. 2021;185:1061-1063.","journal-title":"Br J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","unstructured":"12. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S; ISCL\/EORTC. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713-1722.","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","unstructured":"13. Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, Jaffe ES. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133:1703-1714.","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","unstructured":"14. Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Alfonso Lombardo G, Rupoli S, Alaibac M, Bottoni U, Carbone A, Fava P, Fimiani M, Mamusa AM, Titli S, Zinzani PL, Bernengo MG; Gruppo Italiano Linfomi Cutanei. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Cancer. 2012;118:5830-5839.","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","unstructured":"15. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113:5064-5073.","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.beha.2019.06.004","article-title":"Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and S\u00e9zary syndrome","volume":"32","author":"Martinez","year":"2019","unstructured":"16. Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and S\u00e9zary syndrome. Best Pract Res Clin Haematol. 2019;32:239-252.","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma","volume":"12","author":"Wilson","year":"2012","unstructured":"17. Wilson LD, Hinds GA, Yu JB. Age, race, sex, stage, and incidence of cutaneous lymphoma. Clin Lymphoma Myeloma Leuk. 2012;12:291-296.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A Cutaneous Lymphoma International Prognostic Index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton","year":"2013","unstructured":"18. Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJ. A Cutaneous Lymphoma International Prognostic Index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer. 2013;49:2859-2868.","journal-title":"Eur J Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","unstructured":"19. Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ. Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730-4739.","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdermsci.2009.10.010","article-title":"Prognosis of 100 Japanese patients with mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Suzuki","year":"2010","unstructured":"20. Suzuki SY, Ito K, Ito M, Kawai K. Prognosis of 100 Japanese patients with mycosis fungoides and S\u00e9zary syndrome. J Dermatol Sci. 2010;57:37-43.","journal-title":"J Dermatol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/archderm.135.10.1204","article-title":"Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept","volume":"135","author":"Schmid","year":"1999","unstructured":"21. Schmid MH, Bird P, Dummer R, Kempf W, Burg G. Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. Arch Dermatol. 1999;135:1204-1208.","journal-title":"Arch Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/jdv.15526","article-title":"Epidemiology and prognostic factors for mycosis fungoides and S\u00e9zary syndrome in a multi-ethnic Asian cohort: a 12-year review","volume":"33","author":"Lim","year":"2019","unstructured":"22. Lim HLJ, Tan EST, Tee SI, Ho ZY, Boey JJJ, Tan WP, Tang MBY, Shen L, Chan YH, Tan SH. Epidemiology and prognostic factors for mycosis fungoides and S\u00e9zary syndrome in a multi-ethnic Asian cohort: a 12-year review. J Eur Acad Dermatol Venereol. 2019;33:1513-1521.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Kalay Yildizhan I, Sanli H, Akay BN, Uzundere C, Okcu Heper A. Folliculotropic mycosis fungoides: clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital. Dermatol Ther. 2020;33:e13585.","DOI":"10.1111\/dth.13585"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4172\/2155-9554.1000342","article-title":"Prognostic significance of serum lactate dehydrogenase in Saudi patients with mycosis fungoides: a retrospective study of 47 patients","volume":"7","author":"Al Saif","year":"2016","unstructured":"24. Al Saif F. Prognostic significance of serum lactate dehydrogenase in Saudi patients with mycosis fungoides: a retrospective study of 47 patients. J Clin Exp Dermatol Res. 2016;7:342.","journal-title":"J Clin Exp Dermatol Res"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. ancr\u00e8de-Bohin E, Ionescu MA, de La Salmoni\u00e8re P, Dupuy A, Rivet J, Rybojad M, Dubertret L, Bachelez H, Lebb\u00e9 C, Morel P. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol. 2004;140:1057-1061.","DOI":"10.1001\/archderm.140.9.1057"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5114\/ada.2020.100491","article-title":"Prognostic factors of patients with mycosis fungoides","volume":"37","author":"Bahal\u0131","year":"2020","unstructured":"26. Bahal\u0131 AG, Su O, Cengiz FP, Emiro\u011flu N, Ozkaya DB, Onsun N. Prognostic factors of patients with mycosis fungoides. Postepy Dermatol Alergol. 2020;37:796-799.","journal-title":"Postepy Dermatol Alergol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","article-title":"Lactate: mirror and motor of tumor malignancy","volume":"14","author":"Walenta","year":"2004","unstructured":"27. Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol. 2004;14:267-274.","journal-title":"Semin Radiat Oncol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","unstructured":"28. Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodr\u00edguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH. Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol. 2015;33:3766-3773.","journal-title":"J Clin Oncol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/1346-8138.14692","article-title":"S\u00e9zary syndrome without erythroderma: a case report and review of published work","volume":"46","author":"Kamijo","year":"2019","unstructured":"29. Kamijo H, Miyagaki T, Norimatsu Y, Shishido-Takahashi N, Kuzumi A, Asano Y, Sato S. S\u00e9zary syndrome without erythroderma: a case report and review of published work. J Dermatol. 2019;46:61-64.","journal-title":"J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/archdermatol.2012.2089","article-title":"Differential expression of programmed death-1 (PD-1) in S\u00e9zary syndrome and mycosis fungoides","volume":"148","author":"Cetin\u00f6zman","year":"2012","unstructured":"30. Cetin\u00f6zman F, Jansen PM, Vermeer MH, Willemze R. Differential expression of programmed death-1 (PD-1) in S\u00e9zary syndrome and mycosis fungoides. Arch Dermatol. 2012;148:1379-1385.","journal-title":"Arch Dermatol"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:50:17Z","timestamp":1771833017000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-94412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":30,"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2025.2025.0193","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}